Clinical Trial Update: Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs

View source ↗

Summary

A clinical trial evaluating risk factors, prognosis, clinicopathological features, and metabolic characteristics of early-onset versus late-onset pancreatic neu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Neuroendocrine Tumor

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Pancreatic Neuroendocine Neoplasms (pNETs) | Status: NOT_YET_RECRUITING